Did You Know...
...that in the early 1940s GE engineer James Wright was charged with a task of utmost importance to the war effort: develop a cheap substitute for rubber that could be used to produce tires, gas masks and a whole host of military gear. Wright tackled the task diligently -- and wound up inventing Silly Putty.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188284 | 2-aminoquinolines The present invention relates to compounds of formula (I) wherein A, R1, R2, R3, R4, and R5 are as described herein, pharmaceutical compositions containing them, and me... | 05/29/2012 |
| 8183380 | 2-aminoquinolines The present invention is concerned with 2-aminoquinoline derivatives of formula I where R1, R2, R3, R4, R5, R6, A, and n are as defined in the specification ... | 05/22/2012 |
| 8163923 | Spiro substituted compounds as angiogenesis inhibitors The present invention relates to spiro (tetracarbon) substituted compound of Formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with angiogenesis, such ... | 04/24/2012 |
| 8148532 | Spiro substituted compounds as angiogenesis inhibitors The present invention relates to compound of Formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with angiogenesis, such as cancers associated with prote... | 04/03/2012 |
| 8129533 | Method for production of quinolone-containing lyophilized preparation The present invention is directed to a lyophilized preparation which contains a synthetic quinolone antibacterial compound and, as a solo additive, a pH-adjusting agent, and which exhibits an excellent reconstituting property. The invention provides a method for pro... | 03/06/2012 |
| 8124774 | Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds Disclosed herein is a compound of the formula (I) therapeutic methods, compositions, and medicaments related thereto are also disclosed. ... | 02/28/2012 |
| 8119807 | Quinolynylmethylimidizoles as therapeutic agents Disclosed herein is a compound of the formula (I): (I). Therapeutic methods, compositions and medicaments related thereto are also disclosed. ... | 02/21/2012 |
| 8119808 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators The invention provides for compounds of formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for t... | 02/21/2012 |
| 8106204 | Substituted 2-amino-4-phenyldihydroquinolines, processes for their preparation, pharmaceutical compositions and methods for their use The invention relates to NHE-3 inhibitor compounds of formula I: In which R1-R11 are more specifically defined herein. These substituted 2-amino-4-phenyl-dihydroquinolines are useful the treatment of various renal and respi... | 01/31/2012 |
| 8101767 | Modulators of ATP-binding cassette transporters The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to metho... | 01/24/2012 |
| 8093392 | Caspase inhibitors and uses thereof This invention provides novel compounds, and pharmaceutically acceptable derivatives thereof, that are useful as caspase inhibitors. These compounds have the general formula I: where R1, R2, and R... | 01/10/2012 |
| 8084611 | Process for preparing tetrahydroquinoline derivatives The present invention is to provide a process for preparing optically active tetrahydroquinoline derivatives which can be used for the treatment and/or prevention of diseases such as arteriosclerotic diseases, dyslipidemia and the like, and a process for preparing s... | 12/27/2011 |
| 8076484 | Modified green tea polyphenol formulations Modified green tea polyphenols and methods of their use are provided. One aspect provides compounds and compositions containing green tea polyphenols with one on more ester-linked fatty acids. ... | 12/13/2011 |
| 8071777 | Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine The present invention refers to new compounds derived from artesunate salts with quinolines represented by the general formula (I) where X is represented by the general formula (II) and Y is represented by the general formula (III) depending on the radicals substitu... | 12/06/2011 |
| 8063222 | Aryl sulfonamides useful as inhibitors of chemokine receptor activity The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein R1, X, Z, R2, X1, Ar, n, R3 and R4 are defined gener... | 11/22/2011 |
| 8058442 | Neuroprotective iron chelators and pharmaceutical compositions comprising them Novel iron chelators exhibiting neuroprotective and good transport properties are useful in iron chelation therapy for treatment of a disease, disorder or condition associated with iron overload and oxidative stress, eg. a neurodegenerative or cerebrovascular diseas... | 11/15/2011 |
| 7999108 | Benzyl amines, a process for their production and their use as anti-inflammatory agents The present invention relates to the compounds of formula I, processes for their production and their use as anti-inflammatory agents. ... | 08/16/2011 |
| 7994324 | 2-aminoquinoline derivatives The present invention is concerned with 2-aminoquinoline derivatives, in particular compounds of formula (I) wherein R1 and R2 are as described herein, pharmaceutical compositions containing such compo... | 08/09/2011 |
| 7989628 | 2-aminoquinolines The present invention is concerned with 2-aminoquinoline derivatives of formula I wherein Z, R1, and Ar1 are as defined herein, pharmaceutical compositions containing them, methods for their manufacture. The compounds are 5... | 08/02/2011 |
| 7960551 | Compound A succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof, for use in treating pulmonary disorders. ... | 06/14/2011 |
| 7956188 | Acetamide compounds as fungicides Compounds of the general formula (I); wherein the substituents are as defined in claim 1, are useful as fungicides. ... | 06/07/2011 |
| 7951950 | PGD2 receptor antagonists for the treatment of inflammatory diseases Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein. ... | 05/31/2011 |
| 7939667 | Hepatitis C inhibitor compounds Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protea... | 05/10/2011 |
| 7932392 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof Compounds of Formula (IA) wherein R1, R2, R3, R4 and R5 are as defined herein for Formula (IA), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical composi... | 04/26/2011 |
| 7923561 | Quinolines The present invention relates to 2-Aminoquinoline derivatives of general formula I and pharmaceutically-acceptable acid-addition salts thereof, wherein R1, R2 and X are as defined in the specification.... | 04/12/2011 |
| 7919625 | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML) Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-di... | 04/05/2011 |
| 7906650 | Caspase inhibitors and uses thereof This invention provides novel compounds, and pharmaceutically acceptable derivatives thereof, that are useful as caspase inhibitors. These compounds have the general formula I: where R1, R2, and R... | 03/15/2011 |
| 7897774 | Cyclic compound having quinolylalkylthio group The present invention relates to a synthesis study of novel cyclic compounds having a quinolylalkylthio group represented by the formula (1), and pharmacological actions of the compounds. In the formula, the ring X represen... | 03/01/2011 |
| 7880006 | Quinoline derivatives and insecticide comprising thereof as active ingredient Disclosed are compounds that have excellent insecticidal activity and are usable as agricultural and horticultural insecticides. Compounds represented by formula (I) or agriculturally and horticulturally acceptable acid addition salts thereof have excellent insectic... | 02/01/2011 |
| 7858793 | Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates The present invention relates to the novel compounds Methyl 2-[(3S)-[3-[(2E)(7-chloro quinolin-2-yl)ethenyl]phenyl]-3-halopropyl]benzoates (IV) wherein the halo is chloro, bromo, iodo, starting from the known compound Methyl 2-[(3S)-[3-[(2E)-(7-chloroquinolin-2-yl)e... | 12/28/2010 |
| 7842811 | Cyanine dye compounds Cyanine dye compounds having a negatively charged substituent that are nucleic acid stains, particularly for fluorescent staining of DNA, including compounds having the formula wherein W forms one or two fused 5- or 6-membe... | 11/30/2010 |
| 7825252 | Process and intermediates for preparing integrase inhibitors The invention provides synthetic processes and synthetic intermediates that can be used to prepare 4-oxoquinolone compounds having useful integrase inhibiting properties. ... | 11/02/2010 |
| 7825253 | 2-aminoquinoline derivatives The present invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein X, Y, Ar1, and Ar2 are as defined in the specification. ... | 11/02/2010 |
| 7820824 | Modified carbocyanine dyes and their conjugates Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that a... | 10/26/2010 |
| 7812168 | Purification of montelukast The present invention provides methods of purifying montelukast, a new isolated impurity of montelukast, method for its isolation, and method of using montelukast impurity as a reference marker and a reference standard. ... | 10/12/2010 |
| 7799922 | Aminoquinoline derivatives and their use as adenosine A3 ligands The present invention relates to an adenosine A3 receptor ligand of the general formula (I), within those preferably to the antagonists, including a salt, solvate or isomer (tautomer, desmotrop, and optically active isomer) thereof, to a pharmaceutical co... | 09/21/2010 |
| 7790893 | Modified carbocyanine dyes and their conjugates Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that a... | 09/07/2010 |
| 7781589 | Quantitative method of determining beryllium or a compound thereof in a sample A method of determining beryllium or a beryllium compound thereof in a sample, includes providing a sample suspected of comprising beryllium or a compound thereof, extracting beryllium or a compound thereof from the sample by dissolving in a solution, adding a fluor... | 08/24/2010 |
| 7777039 | Process for the preparation of aripiprazole The present invention relates to an improved process for the preparation of 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-1,2,3,4-tetrahydroquinolin-2-one (Aripiprazole) having dimer impurity less than 0.15%, particularly, the present invention relates to an im... | 08/17/2010 |
| 7745629 | Bicyclic derivatives as modulators of ion channels The present invention relates to bicyclic compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various... | 06/29/2010 |
